Establishment of Biomechanical- and AI- Based Rehabilitation Strategies for Pain Inducing Lifestyles
Launched by BUNDANG CHA HOSPITAL · Jun 6, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to create new ways to help people who live with pain caused by degenerative diseases, like knee or back problems. The researchers aim to find out how certain lifestyle choices can lead to pain and to develop strategies using artificial intelligence to improve treatment through digital devices. The study is currently recruiting participants who are at least 19 years old and either do not have any pain or are experiencing pain from degenerative changes in their knees or backs.
To participate, individuals must be in overall good health and have a clear understanding of the study before agreeing to take part. Participants can expect to contribute to important research that could lead to better pain management solutions in the future. It's important to note that those with certain health issues or infections will not be able to join the study. If you're interested in learning more or think you might qualify, this trial could be a valuable opportunity to help advance pain rehabilitation methods.
Gender
ALL
Eligibility criteria
- • 1. Normal subjects
- • Inclusion criteria
- • 1. Over 19 years of age
- • 2. Those who scored '0' on the Knee/Back Pain Assessment Scale (VAS)
- • 3. After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- • Exclusion criteria
- • 1. Patients who correspond to one or more of the following cannot participate in the study.
- • 2. Those with systemic infectious symptoms at the time of participation in the study
- • 3. Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
- • 4. Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)
- • 2. Subjects who complain pain by degenrative changes in knee
- • Inclusion criteria
- • 1. Over 19 years of age
- • 2. Those who scored '1' or higher on the Knee Pain Assessment Scale (VAS)
- • 3. After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- • Exclusion criteria
- • 1. Patients who correspond to one or more of the following cannot participate in the study.
- • 2. Those with systemic infectious symptoms at the time of participation in the study
- • 3. Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
- • 4. Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)
- • 3. Subjects who complain pain by degenrative changes in back
- • Inclusion criteria
- • 1. Over 19 years of age
- • 2. Those with a back pain rating scale (VAS) of '1' or higher
- • 3. After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- • Exclusion criteria
- • 1. Patients who correspond to one or more of the following cannot participate in the study.
- • 2. Those with systemic infectious symptoms at the time of participation in the study
- • 3. Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
- • 4. Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)
About Bundang Cha Hospital
Bundang CHA Hospital is a leading healthcare institution located in South Korea, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, the hospital leverages its advanced facilities and multidisciplinary expertise to conduct rigorous clinical studies across various therapeutic areas. With a focus on advancing medical knowledge and improving treatment outcomes, Bundang CHA Hospital collaborates with a network of esteemed researchers and healthcare professionals to ensure the highest standards of clinical excellence and ethical practices in all its trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam, , Korea, Republic Of
Patients applied
Trial Officials
Minyoung Kim, M.D., Ph.D.
Principal Investigator
Bundang CHA Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported